Skip to Main Content

Author Details

Giuliano Ciarimboli
University Hospital Munster
1989
104
31
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37108379Overcoming Biological Barriers: Importance of Membrane Transporters in Homeostasis, Disease and Disease Treatment.Int J Mol Sci2023
37511245Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin.Int J Mol Sci2023
37762353Regulation of Transporters for Organic Cations by High Glucose.Int J Mol Sci2023
36979408Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells.Biomolecules2023
35082698Editorial: Mitochondria in Renal Health and Disease, Volume II.Front Physiol2022
35635891Corrigendum to "The role of cholesterol recognition (CARC/CRAC) mirror codes in the allosterism of the human organic cation transporter 2 (OCT2, SLC22A2)" [Biochem. Pharmacol. 194 (2021) 114840].Biochem Pharmacol2022
35458456IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection.Viruses2022
35683007Physiology, Biochemistry and Pharmacology of Transporters for Organic Cations 2.0.Int J Mol Sci2022
36430667Interaction of Masitinib with Organic Cation Transporters.Int J Mol Sci2022
36555515Exacerbation of Cisplatin Cellular Toxicity by Regulation of the Human Organic Cation Transporter 2 through Angiotensin II.Int J Mol Sci2022
35163014Role of Organic Cation Transporter 2 in Autophagy Induced by Platinum Derivatives.Int J Mol Sci2022
35252349Impact of Pals1 on Expression and Localization of Transporters Belonging to the Solute Carrier Family.Front Mol Biosci2022
32772272Contribution and Expression of Organic Cation Transporters and Aquaporin Water Channels in Renal Cancer.Rev Physiol Biochem Pharmacol2021
33718160Case Report and Supporting Documentation: Acute Kidney Injury Manifested as Oliguria Is Reduced by Intravenous Magnesium Before Cisplatin.Front Oncol2021
33732143Regulation Mechanisms of Expression and Function of Organic Cation Transporter 1.Front Pharmacol2021
33559045Influence of Cation Transporters (OCTs and MATEs) on the Renal and Hepatobiliary Disposition of [<sup>11</sup>C]Metoclopramide in Mice.Pharm Res2021
34502566Properties of Transport Mediated by the Human Organic Cation Transporter 2 Studied in a Polarized Three-Dimensional Epithelial Cell Culture Model.Int J Mol Sci2021
34393825Editorial: Mitochondria in Renal Health and Disease.Front Physiol2021
34774844The role of cholesterol recognition (CARC/CRAC) mirror codes in the allosterism of the human organic cation transporter 2 (OCT2, SLC22A2).Biochem Pharmacol2021
34827636Anticancer Platinum Drugs Update.Biomolecules2021
34124075Expression and Function of Organic Cation Transporter 2 in Pancreas.Front Cell Dev Biol2021
33450934Physiology, Biochemistry, and Pharmacology of Transporters for Organic Cations.Int J Mol Sci2021
33380522TrkC Is Essential for Nephron Function and Trans-Activates Igf1R Signaling.J Am Soc Nephrol2021
32109709Fast simultaneous quantification of gabapentin and cetirizine in cell lysates by means of HPLC-MS/MS.J Pharm Biomed Anal2020
32880576Fishing for protective compounds.Elife2020
32708212Rapid Regulation of Human Multidrug and Extrusion Transporters hMATE1 and hMATE2K.Int J Mol Sci2020
32927842Tofacitinib and Baricitinib Are Taken up by Different Uptake Mechanisms Determining the Efficacy of Both Drugs in RA.Int J Mol Sci2020
32149389Cetirizine Reduces Gabapentin Plasma Concentrations and Effect: Role of Renal Drug Transporters for Organic Cations.J Clin Pharmacol2020
30273596Notch Signaling Activity Determines Uptake and Biological Effect of Imatinib in Systemic Sclerosis Dermal Fibroblasts.J Invest Dermatol2019
31653114Protein Abundance of Clinically Relevant Drug Transporters in The Human Kidneys.Int J Mol Sci2019
31493026An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection.Arch Toxicol2019
31318583Identification of the Tetraspanin CD9 as an Interaction Partner of Organic Cation Transporters 1 and 2.SLAS Discov2019
31591331Effects of Single Nucleotide Polymorphism Ala270Ser (rs316019) on the Function and Regulation of hOCT2.Biomolecules2019
30522767The proteome microenvironment determines the protective effect of preconditioning in cisplatin-induced acute kidney injury.Kidney Int2019
29741357Quantitative Bioimaging of Platinum via Online Isotope Dilution-Laser Ablation-Inductively Coupled Plasma Mass Spectrometry.Anal Chem2018
29888219Interaction of the New Monofunctional Anticancer Agent Phenanthriplatin With Transporters for Organic Cations.Front Chem2018
30066585Nephron-specific knockin of the PIKfyve-binding-deficient Vac14<sup>L156R</sup> mutant results in albuminuria and mesangial expansion.Am J Physiol Renal Physiol2018
29530281Single-nephron proteomes connect morphology and function in proteinuric kidney disease.Kidney Int2018
28031320Tetraspanin CD63 controls basolateral sorting of organic cation transporter 2 in renal proximal tubules.FASEB J2017
28455521Importance of the novel organic cation transporter 1 for tyrosine kinase inhibition by saracatinib in rheumatoid arthritis synovial fibroblasts.Sci Rep2017
29416650Organic cation transporter 3 mediates cisplatin and copper cross-resistance in hepatoma cells.Oncotarget2017
29173064Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.Pharmacogenomics2017
29046731Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma.Clin Epigenetics2017
28689374Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity.Clin Transl Sci2017
28002638Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies.Clin Pharmacol Ther2017
26864656In reference to Immunohistochemical localization of OCT2 in the cochlea of various species.Laryngoscope2016
27635733MATE1 regulates cellular uptake and sensitivity to imatinib in CML patients.Blood Cancer J2016
27385173The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations.J Clin Pharmacol2016
27464968The kidney-specific expression of genes can be modulated by the extracellular osmolality.FASEB J2016
26979622A phosphotyrosine switch regulates organic cation transporters.Nat Commun2016
  • 1 - 50 of 104

Recommended Authors

Xiaomin Liang
Gilead Sciences Inc.
Career Start Year 2014
Number of shared co-authors 2
Ganesh Pathare
Institute of Anatomy, University of Zurich
Career Start Year 2011
Number of shared co-authors 1
Eugene C Chen
Department of Drug Metabolism and Pharmacokinetics, Inc.
Career Start Year 2010
Number of shared co-authors 2
Arik A Zur
Schools of Pharmacy and Medicine, University of California san francisco
Career Start Year 2009
Number of shared co-authors 2
Lawrence Lin
University of California San Francisco
Career Start Year 2009
Number of shared co-authors 2
Huan-Chieh Chien
University of California San Francisco
Career Start Year 2007
Number of shared co-authors 5
Kari M Morrissey
Amunix Pharmaceuticals
Career Start Year 2006
Number of shared co-authors 1
Ligong Chen
Tsinghua University
Career Start Year 2006
Number of shared co-authors 1
P??r Matsson
University of Gothenburg
Career Start Year 2005
Number of shared co-authors 2
Bradley L Urquhart
Schulich School of Medicine and Dentistry, Western University
Career Start Year 2003
Number of shared co-authors 0
Sook Wah Yee
University of California San Francisco
Career Start Year 2001
Number of shared co-authors 5
Yasuto Kido
Shionogi & Co.
Career Start Year 1999
Number of shared co-authors 1
Wei Wu
University of California
Career Start Year 1996
Number of shared co-authors 2
Clara E Magyar
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year 1994
Number of shared co-authors 0
Deanna L Kroetz
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 4
Miguel A Valverde
Universitat Pompeu Fabra
Career Start Year 1991
Number of shared co-authors 0
Alan S L Yu
The Jared Grantham Kidney Institute, University of Kansas Medical Center
Career Start Year 1990
Number of shared co-authors 0
Oliver Kretz
University Medical Center Hamburg-Eppendorf
Career Start Year 1989
Number of shared co-authors 3
Olivier Devuyst
Institute of Physiology, University of Zurich, Cliniques Universitaires Saint-Luc
Career Start Year 1989
Number of shared co-authors 2
Francois Pognan
Novartis
Career Start Year 1988
Number of shared co-authors 0
Sanjay K Nigam
university of california san diego
Career Start Year 1986
Number of shared co-authors 2
David M Cohen
Oregon Health and Science University
Career Start Year 1984
Number of shared co-authors 0
Per Artursson
Department of Pharmacy, Uppsala University
Career Start Year 1983
Number of shared co-authors 3
David H Ellison
Oregon Health and Science University
Career Start Year 1982
Number of shared co-authors 0
Bruce A Stanton
Dartmouth College
Career Start Year 1979
Number of shared co-authors 0
Seth L Alper
Beth Israel Deaconess Medical Center RN380F
Career Start Year 1978
Number of shared co-authors 2
Kathleen M Giacomini
University of California San Francisco
Career Start Year 1978
Number of shared co-authors 7
Joseph V Bonventre
Brigham & Women's Hospital
Career Start Year 1975
Number of shared co-authors 0
David S Miller
National Institutes of Health/National Institute of Environmental Health Sciences
Career Start Year 1971
Number of shared co-authors 0
Wolfgang Sad??e
College of Medicine, The Ohio State University
Career Start Year 1967
Number of shared co-authors 2

Collaborators

Eberhard Schlatter
University Hospital Muenster
Co-authored papers 30
Hermann Pavenstädt
Co-authored papers 24
Alex Sparreboom
Ohio State University
Co-authored papers 9
Jason A Sprowl
School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
Co-authored papers 7
Alice A Gibson
The Ohio State University
Co-authored papers 5
Thomas Pap
Co-authored papers 4
Guido Cavaletti
NeuroMI (Milan Center for Neuroscience)
Co-authored papers 4
Lie Li
Sino-French Hoffmann Institute, Guangzhou Medical University
Co-authored papers 4
Navjotsingh Pabla
The Ohio State University
Co-authored papers 4
Shuiying Hu
The Ohio State University
Co-authored papers 3
Guoqing Du
Second Affiliated Hospital of Harbin Medical University
Co-authored papers 3
Markus M Rinschen
Co-authored papers 3
Su Sien Ong
St. Jude Children's Research Hospital
Co-authored papers 2
Andreas Beyer
University of Cologne
Co-authored papers 2
Aksana Vasilyeva
St Jude Children's Research Hospital
Co-authored papers 2
Taosheng Chen
St. Jude Children's Research Hospital
Co-authored papers 2
Sharyn D Baker
Ohio State University
Co-authored papers 2
Jan H M Schellens
Department of Pharmaceutical Sciences, Utrecht University
Co-authored papers 2
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers 1
Shashank Bharill
University of California berkeley
Co-authored papers 1
Marianne Heitzmann
Co-authored papers 1
Robert B Diasio
Mayo Clinic
Co-authored papers 1
Mary V Relling
Departments of Pharmaceutical Sciences.
Co-authored papers 1
Rachel A Ness
4Department of Pharmacy, Memphis Veterans Affairs Medical Center
Co-authored papers 1
John Ziebuhr
Institute of Medical Virology Justus Liebig University
Co-authored papers 1
Ehud Y Isacoff
University of California berkeley
Co-authored papers 1
Anne T Nies
and University of Tuebingen, University of Tuebingen
Co-authored papers 1
Ching-Hon Pui
St. Jude Children's Research Hospital
Co-authored papers 1
Julio Saez-Rodriguez
Institute of Computational Biomedicine, Heidelberg University
Co-authored papers 1
Matthias Schwab
and of Biochemistry and Pharmacy, University of Tuebingen
Co-authored papers 1
Release 1.2